Index by author

July 01, 2003; Volume 70,Issue 7

  1. Bhatt, Deepak L.

    1. Using C-reactive protein to assess cardiovascular disease risk
      Mehdi H. Shishehbor, DO, Deepak L. Bhatt, MD and Eric J. Topol, MD
      Cleveland Clinic Journal of Medicine July 2003, 70 (7) 634-640;

      CRP is now a recognized cardiac test. But who should he tested?

  2. Brainard, Jennifer

    1. New advances transform the management of women with abnormal Pap tests
      Xian Wen Jin, MD, PhD, Craig Nielsen, MD, Jennifer Brainard, MD and Belinda Yen-Lieberman, PhD
      Cleveland Clinic Journal of Medicine July 2003, 70 (7) 641-648;

      We review the new thin-layer slide system, the new HPV test, the 2001 reporting system for Pap tests, and new management guidelines.

  3. Cabral, José M.

    1. Amiodarone-induced thyrotoxicosis: Diagnostic and therapeutic strategies
      Gustavo A. Cardenas, MD, José M. Cabral, MD and Camilo A. Leslie, MD, MBA
      Cleveland Clinic Journal of Medicine July 2003, 70 (7) 624-631;

      It is difficult but important to distinguish the two types of amiodarone-induced thyrotoxicosis.

  4. Cardenas, Gustavo A.

    1. Amiodarone-induced thyrotoxicosis: Diagnostic and therapeutic strategies
      Gustavo A. Cardenas, MD, José M. Cabral, MD and Camilo A. Leslie, MD, MBA
      Cleveland Clinic Journal of Medicine July 2003, 70 (7) 624-631;

      It is difficult but important to distinguish the two types of amiodarone-induced thyrotoxicosis.

  5. Clough, John D.

    1. The promise of molecular biology: Efficacy, safety, wallet depletion
      John D. Clough, MD
      Cleveland Clinic Journal of Medicine July 2003, 70 (7) 584;

      Molecular biology is entering its second wave, with effective but expensive treatments. Recombinant human parathyroid hormone (PTH) is a case in point.

  6. Deal, Chad

    1. Recombinant human PTH 1-34 (Forteo): An anabolic drug for osteoporosis
      Recombinant human PTH 1-34 (Forteo): An anabolic drug for osteoporosis
      Chad Deal, MD and James Gideon, MD, PhD
      Cleveland Clinic Journal of Medicine July 2003, 70 (7) 585-601;

      We have an important new drug for osteoporosis. Now who should get it? And who will pay for it?

  7. Deshmukh, Rashmi

    1. Managing weight gain as a side effect of antidepressant therapy
      Rashmi Deshmukh, MD and Kathleen Franco, MD
      Cleveland Clinic Journal of Medicine July 2003, 70 (7) 314-623;

      Some drugs are more apt to cause weight gain than others; one should inform and work with the patient.

  8. Francis, Gary S.

    1. A 34-year-old man with facial droop and dysarthria
      Ahmed Abdel Latif, MD, Hani Jneid, MD, Carlos M. Isada, MD and Gary S. Francis, MD
      Cleveland Clinic Journal of Medicine July 2003, 70 (7) 602-613;

      A previously well man develops flulike symptoms and neurologic deficits. What is the cause?

  9. Franco, Kathleen

    1. Managing weight gain as a side effect of antidepressant therapy
      Rashmi Deshmukh, MD and Kathleen Franco, MD
      Cleveland Clinic Journal of Medicine July 2003, 70 (7) 314-623;

      Some drugs are more apt to cause weight gain than others; one should inform and work with the patient.

  10. Gideon, James

    1. Recombinant human PTH 1-34 (Forteo): An anabolic drug for osteoporosis
      Recombinant human PTH 1-34 (Forteo): An anabolic drug for osteoporosis
      Chad Deal, MD and James Gideon, MD, PhD
      Cleveland Clinic Journal of Medicine July 2003, 70 (7) 585-601;

      We have an important new drug for osteoporosis. Now who should get it? And who will pay for it?

« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In this issue